Determination of the ELISA kits for screening convalescence plasma with high potency of SARS-CoV-2 IgG
Journal Title: Chinese Journal of Blood Transfusion - Year 2023, Vol 36, Issue 3
Abstract
Objective To determine the ELISA kit for screening convalescence plasma with high potency of SARS-CoV-2 IgG by comparing and analyzing the plasma detection results of convalescent plasma collected in different periods via ELISA kits from two manufacturers and the results of mixed plasma with different potency via pseudovirus neutralization experiments. Methods Two ELISA kits from different manufacturers(named A, B) were used to detect the plasma of 269 convalescent patients collected from Feb.2020~Jan.2022. The correlation and concordance rate of the two results were analyzed to determine the kit preliminarily. According to the titers of diluted series of standard of the preliminary selected kit, 5 mixed plasma samples (G4-G128) with different potency were prepared. The correlation of ELISA IgG results of product A/B, as well as the pseudovirus neutralization test of the original strain, Omicron mutant BA.1 and BA.2 strains were analyzed. Combined with the outside-well dilution mode of the strongly positive samples, the kit for high potency of SARS-CoV-2 IgG screening was determined. Results When the internal control reference B2 was used as the standard, the detection sensitivity of product A and B was 1∶32 vs 1∶8; the detection sensitivity of product A was 4 times that of product B. The correlation Pearson r between the results given by two kits was 0.944 1(P<0.000 1). Product B with low sensitivity was primarily selected as an alternative kit. The ELISA IgG results of samples from mixed plasma showed that the order of correlation r between product A and B was 0.988. The correlation r between product A and neutralization antibody potency of the three viruses was original strain (0.978)>BA.2(0.970)>BA.1(0.799); the order of correlation r between ELISA IgG results of product B and neutralization antibody potency of the three viruses was original strain(0.994)>BA.2(0.968)>BA.1(0.804). If twice-diluted B2 was taken as the excellent standard, 55.4% of product B met the criterion, while 47.2% of product A met.For positive plasma with high IgG potency, the product B kit required a lower dilution of the sample, which was more convenient to operate. Conclusion Both of the ELISA IgG kit from product A and B can be used to screen IgG antibodies of SARS-CoV-2, while product B is more suitable for screening positive plasma with high IgG potency.
Authors and Affiliations
Zhijun ZHOU, Lu FENG, Shenglan YUE, Yan PENG, Bin GAO, Deiming JI, Juan LI, Kejin CHEN, Lianzhen LIN, Cesheng LI, Yong Hu, Taojing Li
Keywords
Related Articles
- EP ID EP738500
- DOI 10.13303/j.cjbt.issn.1004-549x.2023.03.001
- Views 2
- Downloads 0
Hepatitis E virus seroprevalence in Chinese voluntary blood donors: a Meta-analysis by gender and age
Objective To explore the gender and age characteristics of Hepatitis E virus seroprevalence in Chinese voluntary blood donors by Meta-analysis, so as to evaluate the prevalence of HEV and provide reference for blood dono...
Investigation on whole blood collection in Tianjin after fully lifting COVID-19 prevention and control measures
Objective To investigate the situation of whole blood collection in Tianjin after COVID-19 prevention and control measures were fully lifted. Methods The relevant data on whole blood collection of voluntary blood donors...
Application of intelligent information system of transfusion reactions in the supervision and management of transfusion reactions
Objective To analyze the application effect of intelligent information system of transfusion reactions(referred to as the system) in the supervision and management of transfusion reactions. Methods A retrospective analys...
Extracellular vesicles in the blood components and their roles in transfusion-related immunomodulation
Extracellular vesicles (EVs) with a variety of bioactive molecules can be continuously secreted during the storage of blood components, which can promote cell-cell interaction and mediate cell-to-cell signal transmission...
Plasmin-α2-plasmin inhibitor complex and thrombin-antithrombin complex in risk stratification of massive transfusion in patients with postpartum hemorrhage
Objective To analyze the value of plasmin-α2-plasmin inhibitor complex (PIC) and thrombin-antithrombin complex (TAT) for risk stratification of massive transfusion (MT) in patients with postpartum hemorrhage (PPH). Metho...